Biree Andemariam1, Sasia Jones2. 1. Adult Sickle Cell Center, Division of Hematology-Oncology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030, USA. Andemariam@uchc.edu. 2. Adult Sickle Cell Center, Division of Hematology-Oncology, University of Connecticut Health Center, 263 Farmington Avenue, Farmington, CT, 06030, USA. sajones@uchc.edu.
Abstract
BACKGROUND: A national shortage of specialized centers with expertise in the management of adults with sickle cell disease (SCD) remains a concerning public health disparity. Yet, there is an abundance of cancer centers whose operational infrastructure is not only suited to the treatment of the oncology patient, but also can provide medical and procedural care essential to the management of the patient with SCD. Our adult SCD center was formally embedded within an academic hospital-based cancer center in 2009. An evaluation of the impact of this new center has been performed. METHODS: A retrospective chart review was conducted of all SCD encounters occurring 5 years pre- and post-SCD center establishment. Demographic, clinical, as well as hospital utilization and care quality data were compared. RESULTS: The SCD population grew from 22 to 165 patients. Following establishment of the SCD center, patients experienced greater average annual outpatient preventative visits for chronic disease management (1 vs. 4.1) and fewer average hospitalizations yearly (2.4 vs. 1). There was a decrease in hospitalization rates for management of acute pain (50 vs. 23 %), average hospitalization length of stay (12 vs. 6 days), and the proportion of hospital discharges resulting in readmission within 30 days (60 vs. 40 %). Hydroxyurea use among eligible patients increased from 30 to 90 %. CONCLUSION: Findings suggest that embedding adult SCD centers within existing cancer centers can positively impact patterns of health care utilization and improve the quality of care.
BACKGROUND: A national shortage of specialized centers with expertise in the management of adults with sickle cell disease (SCD) remains a concerning public health disparity. Yet, there is an abundance of cancer centers whose operational infrastructure is not only suited to the treatment of the oncology patient, but also can provide medical and procedural care essential to the management of the patient with SCD. Our adult SCD center was formally embedded within an academic hospital-based cancer center in 2009. An evaluation of the impact of this new center has been performed. METHODS: A retrospective chart review was conducted of all SCD encounters occurring 5 years pre- and post-SCD center establishment. Demographic, clinical, as well as hospital utilization and care quality data were compared. RESULTS: The SCD population grew from 22 to 165 patients. Following establishment of the SCD center, patients experienced greater average annual outpatient preventative visits for chronic disease management (1 vs. 4.1) and fewer average hospitalizations yearly (2.4 vs. 1). There was a decrease in hospitalization rates for management of acute pain (50 vs. 23 %), average hospitalization length of stay (12 vs. 6 days), and the proportion of hospital discharges resulting in readmission within 30 days (60 vs. 40 %). Hydroxyurea use among eligible patients increased from 30 to 90 %. CONCLUSION: Findings suggest that embedding adult SCD centers within existing cancer centers can positively impact patterns of health care utilization and improve the quality of care.
Entities:
Keywords:
Cancer center; Quality; Sickle cell disease; Utilization
Authors: A Christoforidou; D Pantelidou; A Anastasiadis; A Goutzouvelidis; D Margaritis; I Kotsianidis; E Spanoudakis; V Kaloutsi; G Bourikas; C Tsatalas Journal: Acta Haematol Date: 2009-01-08 Impact factor: 2.195
Authors: Otis W Brawley; Llewellyn J Cornelius; Linda R Edwards; Vanessa Northington Gamble; Bettye L Green; Charles Inturrisi; Andra H James; Danielle Laraque; Magda Mendez; Carolyn J Montoya; Brad H Pollock; Lawrence Robinson; Aaron P Scholnik; Melissa Schori Journal: Ann Intern Med Date: 2008-05-05 Impact factor: 25.391
Authors: Susan M Downes; Ian R Hambleton; Elaine L Chuang; Noemi Lois; Graham R Serjeant; Alan C Bird Journal: Ophthalmology Date: 2005-09-19 Impact factor: 12.079
Authors: Martin H Steinberg; William F McCarthy; Oswaldo Castro; Samir K Ballas; F Danny Armstrong; Wally Smith; Kenneth Ataga; Paul Swerdlow; Abdullah Kutlar; Laura DeCastro; Myron A Waclawiw Journal: Am J Hematol Date: 2010-06 Impact factor: 10.047
Authors: Barbara P Yawn; George R Buchanan; Araba N Afenyi-Annan; Samir K Ballas; Kathryn L Hassell; Andra H James; Lanetta Jordan; Sophie M Lanzkron; Richard Lottenberg; William J Savage; Paula J Tanabe; Russell E Ware; M Hassan Murad; Jonathan C Goldsmith; Eduardo Ortiz; Robinson Fulwood; Ann Horton; Joylene John-Sowah Journal: JAMA Date: 2014-09-10 Impact factor: 56.272
Authors: Louis-Philippe Laurin; Patrick H Nachman; Payal C Desai; Kenneth I Ataga; Vimal K Derebail Journal: Nephrol Dial Transplant Date: 2013-09-30 Impact factor: 5.992
Authors: Michel Delforge; Dominik Selleslag; Yves Beguin; Agnès Triffet; Philippe Mineur; Koen Theunissen; Carlos Graux; Fabienne Trullemans; Dominique Boulet; Koen Van Eygen; Lucien Noens; Steven Van Steenweghen; Jan Lemmens; Pascal Pierre; Randal D'hondt; Augustin Ferrant; Dries Deeren; Ann Van De Velde; Wim Wynendaele; Marc André; Robrecht De Bock; André Efira; Dimitri Breems; Anne Deweweire; Kurt Geldhof; Wim Pluymers; Amanda Harrington; Karen MacDonald; Ivo Abraham; Christophe Ravoet Journal: Leuk Res Date: 2014-02-14 Impact factor: 3.156
Authors: Julie Kanter; Wally R Smith; Payal C Desai; Marsha Treadwell; Biree Andemariam; Jane Little; Diane Nugent; Susan Claster; Deepa G Manwani; Judith Baker; John J Strouse; Ifeyinwa Osunkwo; Rosalyn W Stewart; Allison King; Lisa M Shook; John D Roberts; Sophie Lanzkron Journal: Blood Adv Date: 2020-08-25